Sector ratings Orion Oyj

Equities

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2025-12-12 EST			5-day change	1st Jan Change
60.05 ^EUR	-1.96%		-1.31%	+40.37%

12-03	Orion Lifts FY25 Outlook on Expectation of Milestone Payment for Prostate Cancer Drug	MT
12-03	Orion updates full-year outlook for 2025	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ORION OYJ	9.9B		AA
ELI LILLY AND COMPANY	920B		A
JOHNSON & JOHNSON	510B		BBB
ABBVIE INC.	395B		AA
ROCHE HOLDING AG	340B		AA
ASTRAZENECA PLC	278B		A
NOVARTIS AG	254B		AAA
MERCK & CO., INC.	249B		A
NOVO NORDISK A/S	224B		A
AMGEN INC.	171B		A
GILEAD SCIENCES, INC.	149B		AAA
PFIZER INC.	147B		BBB
SANOFI	119B		A
VERTEX PHARMACEUTICALS INCORPORATED	115B		AA
BRISTOL-MYERS SQUIBB COMPANY	107B		A
GSK PLC	97.84B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	90.26B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	59.5B		AA
ALNYLAM PHARMACEUTICALS, INC.	52.52B		AA	-
Average	217.62B		AA
Weighted average by Cap.			AA